Tricuspid Valve

This channel is dedicated to news and trends in tricuspid valve interventions, surgical and transcatheter, to manage regurgitation and valve stenosis. The tricuspid valve is a rapidly growing area in structural heart interventions. Minimally invasive transcatheter tricuspid valve replacement (TTVR) and repair using transcatheter edge to edge repair (TEER) clips are expected to become a new standard of care in the next couple years, partly because open heart tricuspid surgery has historically has poor outcomes.

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival
Researchers tracked data from more than 600 patients, noting that heart teams may want to reconsider how they classify residual TR after treatment.
Society of Thoracic Surgeons launches new risk calculators for SAVR after TAVR, other key heart surgeries
STS risk calculators are known as a go-to resource for cardiologists, surgeons and any other healthcare providers who manage the care of heart patients.
Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation
The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview.
FDA approves Abbott’s TriClip TEER device for tricuspid regurgitation
Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.

Adam Greenbaum, MD, Emory, explains the CLASP TR trial of the Pascal clip device for transcatheter repair, which was a late-breaking ACC22 study.

VIDEO: Pascal effective in transcatheter repair of tricuspid valve regurgitation

Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.

April 12, 2022

Tricuspid valve annuloplasty during mitral valve surgery offers key benefits

The new analysis focused on 98 patients who presented with primary mitral regurgitation.

February 7, 2022

TTVR patients see consistent improvements in their daily lives

Researchers evaluated 115 patients before and one month after undergoing transcatheter tricuspid valve repair, sharing their findings in JACC: Cardiovascular Interventions.

December 8, 2021

TAVR provides comparable value for low-risk patients with bicuspid and tricuspid AS

Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves.

September 24, 2021

Abbott’s TriClip a safe, effective treatment option for severe tricuspid regurgitation

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%.

May 21, 2021

FDA grants breakthrough device designation to Medtronic TTVR system, approves early feasibility study

According to Medtronic, its Intrepid TTVR system helps meet a “large, unmet clinical need.”

September 9, 2020

TTVR improves outcomes for patients with severe tricuspid regurgitation

Transcatheter edge-to-edge tricuspid valve repair (TTVR) is an effective treatment option for patients with severe tricuspid regurgitation (TR), according to a new study published in JACC: Heart Failure.

April 13, 2020

Tricuspid Valve

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival

Society of Thoracic Surgeons launches new risk calculators for SAVR after TAVR, other key heart surgeries

Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation

Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair

FDA approves Abbott’s TriClip TEER device for tricuspid regurgitation